Amphastar Pharmaceuticals, Inc. Operating Margin in % from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to Q3 2025.
  • Amphastar Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2025 was 20.7 %, a 30% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Operating Margin for 2024 was 28.1 %, a 8.21% decline from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Operating Margin for 2023 was 30.6 %, a 41.9% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Operating Margin for 2022 was 21.5 %, a 35% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Amphastar Pharmaceuticals, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 20.7 -8.88 -30% Jul 1, 2025 Sep 30, 2025
Q2 2025 25.1 -7.11 -22% Apr 1, 2025 Jun 30, 2025
Q1 2025 26.7 -4.64 -14.8% Jan 1, 2025 Mar 31, 2025
Q4 2024 28.1 -2.51 -8.21% Oct 1, 2024 Dec 31, 2024
Q3 2024 29.6 -0.46 -1.53% Jul 1, 2024 Sep 30, 2024
Q2 2024 32.3 +7.96 +32.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 31.3 +8.28 +36% Jan 1, 2024 Mar 31, 2024
Q4 2023 30.6 +9.03 +41.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 30.1 +10.7 +55.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 24.3 +4.28 +21.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 23 +5.17 +29% Jan 1, 2023 Mar 31, 2023
Q4 2022 21.5 +5.58 +35% Oct 1, 2022 Dec 31, 2022
Q3 2022 19.4 +7.62 +64.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 20 +12.9 +182% Apr 1, 2022 Jun 30, 2022
Q1 2022 17.8 +14.1 +377% Jan 1, 2022 Mar 31, 2022
Q4 2021 16 +12.8 +410% Oct 1, 2021 Dec 31, 2021
Q3 2021 11.8 +9.43 +406% Jul 1, 2021 Sep 30, 2021
Q2 2021 7.1 +5.09 +253% Apr 1, 2021 Jun 30, 2021
Q1 2021 3.74 +0.5 +15.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 3.13 +3.14 Oct 1, 2020 Dec 31, 2020
Q3 2020 2.32 +1.79 +336% Jul 1, 2020 Sep 30, 2020
Q2 2020 2.01 +1.43 +244% Apr 1, 2020 Jun 30, 2020
Q1 2020 3.24 +3.88 Jan 1, 2020 Mar 31, 2020
Q4 2019 -0.01 +2.91 +99.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 0.53 +5.09 Jul 1, 2019 Sep 30, 2019
Q2 2019 0.59 +7.68 Apr 1, 2019 Jun 30, 2019
Q1 2019 -0.64 +4.51 +87.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -2.93 -2.4 -454% Oct 1, 2018 Dec 31, 2018
Q3 2018 -4.55 Jul 1, 2018 Sep 30, 2018
Q2 2018 -7.09 Apr 1, 2018 Jun 30, 2018
Q1 2018 -5.15 Jan 1, 2018 Mar 31, 2018
Q4 2017 -0.53 Oct 1, 2017 Dec 31, 2017

Amphastar Pharmaceuticals, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 28.1 -2.51 -8.21% Jan 1, 2024 Dec 31, 2024
2023 30.6 +9.03 +41.9% Jan 1, 2023 Dec 31, 2023
2022 21.5 +5.58 +35% Jan 1, 2022 Dec 31, 2022
2021 16 +12.8 +410% Jan 1, 2021 Dec 31, 2021
2020 3.13 +3.14 Jan 1, 2020 Dec 31, 2020
2019 -0.01 +2.91 +99.4% Jan 1, 2019 Dec 31, 2019
2018 -2.93 -2.4 -454% Jan 1, 2018 Dec 31, 2018
2017 -0.53 -6.55 -109% Jan 1, 2017 Dec 31, 2017
2016 6.03 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.